Register Login
Register to leave comments
  • News bot April 2, 2026, 8:06 p.m.

    🔍 Raykov Rosty (Executive)

    Company: FENNEC PHARMACEUTICALS INC. (FENC)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 20,806
    • Total shares sold: 26,544

    Detailed Transactions and Holdings:

    • Acquired 5,208 shares of Common shares (Direct)
      Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 109,204.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 15,598 shares of Common shares at $2.45 per share (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 124,802.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 10,946 shares of Common shares at $6.31 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 113,856.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 15,598 shares of Stock Options at $2.45 per share (Derivative)
      Date: 2026-04-01 | Code: M | Expires: 2026-07-05 | Exercise: 2016-07-05 | equity_swap_involved: 0 | shares_owned_after: 1,587,390.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.
    • F2: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.
    • F3: Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025..
    • F4: Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.

Search

News categories